Lansforsakringar Fondforvaltning AB publ Acquires 11,679 Shares of Ventas, Inc. $VTR

Lansforsakringar Fondforvaltning AB publ grew its stake in shares of Ventas, Inc. (NYSE:VTR) by 8.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 143,123 shares of the real estate investment trust’s stock after acquiring an additional 11,679 shares during the quarter. Lansforsakringar Fondforvaltning AB publ’s holdings in Ventas were worth $10,017,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of VTR. Cloud Capital Management LLC bought a new position in shares of Ventas during the 3rd quarter valued at approximately $25,000. True Wealth Design LLC boosted its stake in Ventas by 1,557.7% in the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after purchasing an additional 405 shares during the period. ORG Partners LLC grew its stake in Ventas by 76.1% during the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 197 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its holdings in shares of Ventas by 65.5% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 180 shares during the last quarter. Finally, Golden State Wealth Management LLC increased its holdings in shares of Ventas by 52.7% in the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 185 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Insider Activity

In other news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer owned 1,114,034 shares in the company, valued at $86,515,880.44. This trade represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 86,106 shares of company stock worth $6,931,397 in the last ninety days. Company insiders own 1.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Royal Bank Of Canada lifted their price objective on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 10th. Morgan Stanley set a $90.00 price target on Ventas in a report on Friday, February 13th. Argus set a $88.00 target price on shares of Ventas in a research note on Tuesday, February 10th. Citigroup boosted their target price on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $93.00 target price on shares of Ventas in a research report on Monday, December 15th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $86.87.

Ventas Trading Up 0.8%

Ventas stock opened at $86.61 on Tuesday. Ventas, Inc. has a one year low of $60.15 and a one year high of $87.24. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67. The stock has a market cap of $41.14 billion, a PE ratio of 160.39, a price-to-earnings-growth ratio of 2.10 and a beta of 0.77. The stock has a 50-day moving average of $79.41 and a two-hundred day moving average of $74.67.

Ventas (NYSE:VTR) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the business earned $0.81 EPS. The business’s revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, research analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s payout ratio is currently 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.